Persistent enlargement of the pancreatic gland after glucocorticoid therapy increases the risk of relapse in IgG4-related autoimmune pancreatitis

• Published in: Clinical rheumatology Vol. 41; no. 6; pp. 1709 - 1718
• Main Authors: Lu, Hui, Peng, Linyi, Zhu, Liang, Feng, Ruie, Zhou, Jiaxin, Liu, Zheng, Li, Jieqiong, Luo, Xuan, Peng, Yu, Qin, Chenman, Fei, Yunyun, Zhao, Yan, Zeng, Xiaofeng, Lai, Yamin, Zhang, Wen
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.06.2022; Springer Nature B.V
• Subjects: Atrophy; Diagnosis; Glucocorticoids; Immunoglobulin G; Medicine; Medicine & Public Health; Original Article; Pancreas; Pancreatitis; Patients; Regression analysis; Rheumatology; Risk factors; Salivary gland; Survival analysis; Atrophy; IgG4-related autoimmune pancreatitis; Relapse; Swelling
• ISSN: 0770-3198; 1434-9949; 1434-9949
• DOI: 10.1007/s10067-022-06091-5

Objectives This study aims to clarify the relationship between the changes of pancreatic size after glucocorticoid (GC) therapy and relapse in IgG4-related autoimmune pancreatitis (AIP). Methods We prospectively enrolled 205 newly diagnosed IgG4-related AIP patients. 145 patients were followed up fo...